AppLovin was added to the S&P 500 in September. The company is expanding beyond its gaming niche, which is something ...

Antibodies serve as foundational tools across a broad range of research fields from immunology to oncology and infectious ...

Now, it’s worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 196% for the S&P 500. Don’t miss out on the latest top 10 list, available when you ...

Fintel reports that on October 30, 2025, Citigroup maintained coverage of Bio-Rad Laboratories (NYSE:BIO.B) with a Buy recommendation. Analyst Price Forecast Suggests 21.85% Upside As of April 2, 2025 ...

LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...

(MENAFN- GlobeNewsWire - Nasdaq) Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE ...

Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third ...

Shanghai International Studies University launches the Neurocognitive Image Laboratory at an event in Shanghai on Tuesday. [Photo provided to chinadaily.com.cn] To address national strategic needs and ...

The healthcare sector’s slump had created opportunities for stock-pickers rather than broad sector gains, Goldman Sachs strategist David Kostin said.

The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.